12:00 AM
 | 
May 03, 2010
 |  BC Week In Review  |  Company News  |  Other News

AstraZeneca neurology news

AstraZeneca said it finalized a previously announced agreement in principle with several federal and state agencies and will pay $520 million to resolve civil allegations related to off-label marketing and promotion of Seroquel...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >